期刊文献+

尿酸-帕金森病防治的潜在新靶点 被引量:7

Potential novel target in preventing Parkinson's disease: uric acid
原文传递
导出
摘要 帕金森病(Parkinson’s disease,PD)是中老年人常见的运动障碍疾病,氧化应激和线粒体功能障碍与PD患者黑质多巴胺能神经元变性、丢失密切相关。近年来的研究发现尿酸水平的高低对PD的发病以及发病后疾病的进展快慢有显著影响。本文将就尿酸的生物学特性及其与PD的关系做一综述。
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2012年第11期1179-1181,共3页 Chinese Journal of Neuromedicine
关键词 尿酸 帕金森病 氧化应激 神经保护 Uric acid Parkinson's disease Oxidative stress Neuroprotection
  • 相关文献

参考文献8

二级参考文献101

  • 1蔡晓杰,陈海波,王新德,贡慧华.帕金森病患者的智能障碍—瑞文测验的应用及意义[J].脑与神经疾病杂志,1997,5(2):94-96. 被引量:13
  • 2Jenner P. Oxidative stress in Parkinson' s disease. Ann Neural, 2003,53 Suppl 3 :S26-S38.
  • 3Hink HU, Santanam N, Dikalov S, et al. Peroxidase properties of extraceUular superoxide dismutase:role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol, 2002,22 : 1402- 1408.
  • 4Duan W, Ladenheim B, Cutler RG, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson' s disease. J Neurochem, 2002, 80 : 101-110.
  • 5Fitzmaurice PS, Ang L, Guttman M, et al. Nigral glutathione deficiency is not specific for idiopathic Parkinson' s disease. Mov Disord, 2003,18:969-976.
  • 6Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson' s disease. Age Ageing, 1999, 28 : 99-102.
  • 7Church WH,Ward VL Uric acid is reduced in the substantia nigra in Parkinsen' s disease: effect on dopamine oxidation. Brain Res Bull,1994, 33: 419-425.
  • 8Kim TS, Pae CU, Yoon SJ, et al. Decreased plasma antioxidants in patients with Alzheimer' s disease. Int J Geriatr Psychiatry, 2006,21:344-348.
  • 9Rentzos M, Nikolaou C, Anagnostouli M, et al. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg, 2006, 108 : 527- 531.
  • 10Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev, 2007,87:315-424.

共引文献83

同被引文献51

  • 1龚守会,陈全凤,朱贵忠,张贵斌,宋金辉,罗韵文.帕金森病患者血尿酸水平的检测及其临床意义[J].中国全科医学,2009,12(7):595-596. 被引量:6
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 3Schlesinger L, Schlesinger N. Uric acid in Parkinson' s disease. Mov disord,2008,23 (12) : 1653-1657.
  • 4Sheard JM, Ash S, Silburn PA, et al. Prevalence of malnutrition in Parkinson ' s disease: a systematic review. Nutr Rev,2011,69 (9) : 520-532.
  • 5Cipriani S,Chen X,Schwarzschild MA.Urate:a novel biomarker of Parkinson' s disease risk,diagnosis and prognosis[J].Biomark Med,2010,4(5):701-712.
  • 6Weisskopf MG,OReilly E,Chen H,et al.Plasma urate and risk of Parkinson' s disease[J].Am J Epidemio1,2007,166 (5):561-567.
  • 7Schlesinger I,Schlesinger N.Uric acid in Parkinson' s disease[J].Mov Disord,2008,23 (12):1653-1657.
  • 8Fitzmaurice PS,Ang L,Guttman M,et al.Nigral glutathione deficiency is not specific for idiopathic Parkinson' s disease[J].Mov Disord,2003,18(9):969-976.
  • 9Andreadou E,Nikolaou C,Goumaras F,et al.Serum uric acid levels in patients with Parkinson ' s disease:their relationship to treatment and disease duration[J].Clin Neurol Neurosurg,2009,111 (9):724-728.
  • 10De Vera M,Rahman MM,Rankin J,et al.Gout and the risk of Parkinson' s disease:a cohort study[J].Arthritis Rheum,2008,59 (11):1549-1954.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部